What Is Semafull? Natco Pharma Semaglutide in India
A practical beginner guide explaining What Is Semafull? Natco Pharma Semaglutide in India, how it works, who it may be for, and what to discuss before startin
What Is Semafull? Natco Pharma Semaglutide in India
The landscape of managing type 2 diabetes and body weight is evolving, and new medications are becoming part of the conversation in India. One name that has recently emerged is Semafull, a product from the Indian pharmaceutical company Natco Pharma. If you've heard this name and are curious to understand what it is, this guide offers a clear and practical overview.
This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any medication.
The Science Behind the Name: What is Semaglutide?
To understand Semafull, we first need to talk about its active ingredient: semaglutide.
Semaglutide belongs to a class of medicines known as GLP-1 receptor agonists. GLP-1 (glucagon-like peptide-1) is a natural hormone your body produces. It plays a crucial role in managing your blood sugar levels and appetite.
GLP-1 receptor agonists work by mimicking the action of this natural hormone. They are not a form of insulin, but they help your body regulate its own systems more effectively, particularly after you eat.
Introducing Semafull: Natco Pharma's Semaglutide
Semafull is the brand name under which Natco Pharma is marketing its semaglutide product in India. It is a prescription medication that has received approval from the Central Drugs Standard Control Organisation (CDSCO), India's national regulatory body.
The initial approval for Semafull in India is for the management of type 2 diabetes. Globally, semaglutide has garnered significant attention for its effects on both blood sugar control and weight management, which is why it is a topic of great interest.
How Does Semafull (Semaglutide) Actually Work?
The way semaglutide works is multi-faceted, targeting several key bodily functions to help manage blood sugar. These effects can also influence appetite and body weight.
It Encourages Insulin Release
When your blood sugar rises after a meal, semaglutide stimulates your pancreas to release insulin. Insulin is the hormone that helps move sugar from your blood into your cells to be used for energy. This action helps prevent blood sugar levels from getting too high.
It Reduces Glucagon Secretion
Semaglutide also helps to reduce the amount of glucagon released by the pancreas. Glucagon is a hormone that has the opposite effect of insulin; it tells your liver to release stored sugar into the bloodstream. By curbing this, semaglutide helps keep blood sugar levels more stable.
It Slows Down Digestion
One of the most notable effects of semaglutide is that it slows down gastric emptying. This means that food stays in your stomach for a longer period. This slower pace helps prevent sharp spikes in blood sugar after meals and can contribute to a feeling of fullness, or satiety.
It May Influence Appetite Signals
GLP-1 receptors are also found in the brain. By acting on these receptors, semaglutide can help reduce appetite and food cravings, which may lead to a lower calorie intake.
Who Might Be a Candidate for This Medication?
Semafull is a prescription medication, and the decision to use it can only be made by a qualified doctor.
Currently, its approved indication in India is for adults with inadequately controlled type 2 diabetes, used as an adjunct to diet and exercise. A doctor will evaluate a person's overall health, medical history, existing conditions, and treatment goals before considering it as an option.
It is not a first-line treatment for everyone. The decision is based on a comprehensive medical assessment, and it's meant to be part of a broader management plan that includes lifestyle changes like a balanced diet and regular physical activity.
Important Conversations to Have With Your Doctor
Starting any new medication is a significant decision. If you and your doctor are considering Semafull, it is vital to have an open and thorough discussion.
Here are some key topics to cover:
- Your Complete Medical History: Be sure to discuss any past or present medical conditions, especially those related to your pancreas, kidneys, or thyroid. Mention any history of diabetic retinopathy.
- All Current Medications: Provide a full list of all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you are taking.
- Potential Side Effects: Ask your doctor about the common side effects associated with semaglutide. The most frequently reported ones are gastrointestinal, such as nausea, vomiting, diarrhoea, and constipation. Understanding what to expect can help you manage them if they occur.
- How to Use the Medication: Semafull is an injectable medication. Ensure you receive clear instructions on how to properly administer the injection, how to store it, and what to do if you miss a dose.
- Lifestyle Integration: Discuss how this medication fits into your overall health plan. Medication works best when combined with sustainable diet and exercise habits.
A Measured Perspective
Semafull represents a new option within the Indian healthcare system for managing type 2 diabetes. Its active ingredient, semaglutide, works by tapping into the body's natural hormonal systems to help regulate blood sugar and appetite.
However, it is not a simple or quick fix. It is a powerful medication that requires careful medical supervision to ensure it is used safely and effectively. The journey to better health is a partnership between you and your healthcare team.
Consult your healthcare provider before starting any medication.
Sources
- Natco Pharma Limited. (2024, February 13). Press Release on launch of SEMAFULL. https://www.natcopharma.co.in/wp-content/uploads/2024/02/Press-Release-on-launch-of-SEMAFULL.pdf
- U.S. National Library of Medicine. (2024). Semaglutide Injection. MedlinePlus. https://medlineplus.gov/druginfo/meds/a618008.html
- Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine, 384(11), 989–1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- Mayo Clinic. (2023). Semaglutide (Subcutaneous Route) Description and Brand Names. https://www.mayoclinic.org/drugs-supplements/semaglutide-subcutaneous-route/description/drg-20406730
- World Health Organization (WHO). (2023). Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes
Written by
Dietician / Nutritionist
Health Content Writer
Neha Kumari is a Dietician / Nutritionist professional who contributes evidence-informed health and wellness content for WeightEasy.
View profile →Reviewed by
Immunobiologist
Senior Medical Reviewer
Dr kshama jain is a Immunobiologist professional who reviews WeightEasy health content for medical and editorial accuracy.
View profile →